Basal release of nitric oxide augments the Frank-Starling response in the isolated heart

Circulation

Volumn 96, Issue 4, 1997, Pages 1320-1329

  Prendergast, Bernard D ^a   Sagach, Vadim F ^b   Shah, Ajay M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

Author keywords

Cardiac output; Endothelium derived factors; Myocardial contraction; Ventricles

Indexed keywords

ARGININE; HEMOGLOBIN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PROSTAGLANDIN F2 ALPHA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; GUINEA PIG; HEART CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE RELAXATION; HEART OUTPUT; HEART PRELOAD; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; STARLING LAW;

EID: 0030791770     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.4.1320     Document Type: Article

References (49)

1. Lakatta EG. Length modulation of muscle performance: Frank-Starling law of the heart. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. New York, NY: Raven Press; 1992:1325-1351.
2. Crozatier B. Stretch-induced modifications of myocardial performance: from ventricular function to cellular and molecular mechanisms. Cardiovasc Res. 1996;32:25-37.
3. Drake-Holland AJ, Mills CJ, Noble MIM, Pugh S. Responses to changes in filling and contractility of indices of human left ventricular mechanical performance. J Physiol. 1990;422:29-39.
4. Plotnick GD, Becker LC, Fisher ML, Gerstenblith G, Renlund DG, Fleg JL, Weisfeldt ML, Lakatta EG. Use of the Frank-Starling mechanism during submaximal versus maximal upright exercise. Am J Physiol. 1986;251:H1101-H1105.
5. Higginbotham MB, Morris KG, Sanders Williams R, McHale PA, Coleman RE, Cobb FR. Regulation of stroke volume during submaximal and maximal upright exercise in normal man. Circ Res. 1986;58:281-291.
6. Sato H, Hori M, Ozaki H, Yokoyama H, Imai K, Morikawa M, Takeda H, Inoue M, Kamada T. Exercise-induced upward shift of diastolic left ventricular pressure-volume relation in patients with dilated cardiomyopathy: effects of β-adrenoceptor blockade. Circulation. 1993;88:2215-2223.
7. Komamura K, Shannon RP, Ihara T, Shen YT, Mirsky I, Bishop SP, Vatner SF. Exhaustion of Frank-Starling mechanism in conscious dogs with heart failure. Am J Physiol. 1993;265:H1119-H1131.
8. Parmley WW, Chuck L. Length-dependent changes in myocardial contractile state. Am J Physiol. 1973;224:1195-1199.
9. Fabiato A, Fabiato F. Dependence of the contractile activation of skinned cardiac cells on the sarcomere length. Nature. 1975;256: 54-56.
10. Lakatta EG, Jewell BR. Length-dependent activation: its effect on the length-tension relation in cat ventricular muscle. Circ Res. 1977; 40:251-257.
11. Allen DG, Kurihara S. The effects of muscle length on intracellular calcium transients in mammalian cardiac muscle. J Physiol. 1982; 327:79-94.
12. Tucci PJF, Bregagnollo EA, Spadaro J, Cicogna AC, Ribiero MCL. Length-dependence of activation studied in the isovolumic blood-perfused dog heart. Circ Res. 1984;55:59-66.
13. Sugiura S, Hunter WC, Sagawa K. Long-term versus intrabeat history of ejection as determinants of canine ventricular end-systolic pressure. Circ Res. 1989;64:255-264.
14. Hibberd MG, Jewell BR. Calcium- and length-dependent force production in rat ventricular muscle. J Physiol. 1982;329:527-540.
15. 2+ binding to cardiac troponin C. Am J Physiol. 1987;253: C90-C96.
16. Brutsaert DL, Andries LJ. The endocardial endothelium. Am J Physiol. 1992;263:H985-H1002.
17. Ramaciotti C, McClellan G, Sharkey A, Rose D, Wiseberg A, Winegrad S. Cardiac endothelial cells modulate contractility of rat heart in response to oxygen tension and coronary flow. Circ Res. 1993;72:1044-1064.
18. Shah AM. Paracrine modulation of heart cell function by endothelial cells. Cardiovasc Res. 1996;31:847-867.
19. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A. 1993;90:347-351.
20. Balligand JL, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW, Michel T. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem. 1995;270:14582-14586.
21. Smith JA, Shah AM, Lewis MJ. Factors released from the endocardium of the ferret and pig modulate myocardial contraction. J Physiol. 1991;439:1-14.
22. Grocott-Mason R, Fort S, Lewis MJ, Shah AM. Myocardial relaxant effect of exogenous nitric oxide in the isolated ejecting heart. Am J Physiol. 1994;266:H1699-H1705.
23. Grocott-Mason RM, Anning PB, Evans H, Lewis MJ, Shah AM. Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol. 1994;267:H1804-H1813.
24. Shah AM, Spurgeon H, Sollott SJ, Talo A, Lakatta EG. 8-Bromo cyclic GMP reduces the myofilament response to calcium in intact cardiac myocytes. Circ Res. 1994;74:970-978.
25. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in man. Circulation. 1994;89:2070-2078.
26. Paulus WJ, Vantrimpont PJ, Shah AM. Paracrine coronary endothelial control of left ventricular function in humans. Circulation. 1995;92:2119-2126.
27. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 1995;92:2198-2203.
28. 2+ current. J Biol Chem. 1994;268:26286-26295.
29. Mohan P, Brutsaert DL, Paulus WJ, Sys SU. Myocardial contractile response to nitric oxide and cGMP. Circulation. 1996;93:1223-1229.
30. Finkel MS, Oddis CV, Mayer OH, Hattler BG, Simmons RL. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J Pharmacol Exp Ther. 1995;272:945-952.
31. Kaye DM, Wiviott SD, Balligand JL, Simmons WW, Smith TW, Kelly RA. Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of contractile function in adult rat ventricular myocytes. Circ Res. 1996;78:217-224.
32. Shah AM, Lewis MJ, Henderson AH. Effects of 8-bromo-cyclic GMP on contraction and on inotropic response of ferret cardiac muscle. J Mol Cell Cardiol. 1990;23:55-64.
33. Shah AM, Silverman HS, Griffith EJ, Spurgeon HA, Lakatta EG. Cyclic GMP prevents delayed relaxation at reoxygenation following brief hypoxia in isolated cardiac myocytes. Am J Physiol. 1995;268: H2396-H2404.
34. Pfitzer G, Rüegg JC, Flockerzi V, Hofmann F. cGMP-dependent protein kinase decreases calcium sensitivity of skinned cardiac fibers. FEBS Lett. 1982;149:171-175.
35. Ludbrook J. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res. 1994;28:303-311.
36. Suga H, Sagawa K, Shoukas AA. Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of norepinephrine and heart rate on the ratio. Circ Res. 1973;32:314-322.
37. Beresewicz A, Wozniak M. Mechanical performance and coronary flow adjustments to changes in workload are not affected by inhibiting nitric oxide production in working rat heart. Pol J Pharmacol. 1993;45:533-548.
38. Amrani M, O'Shea J, Allen NJ, Harding SE, Jayakumar J, Pepper JR, Moncada S, Yacoub MH. Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart. J Physiol. 1992;456:681-687.
39. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD. The role of nitric oxide in cardiac depression induced by interleukin-1β and tumor necrosis factor-α. Br J Pharmacol. 1995; 114:27-34.
40. Salisbury PF, Cross CE, Riebed PA. Influence of coronary pressure on myocardial elasticity. Circ Res. 1960;8:794-800.
41. Keller TCS. Structure and function of titin and nebulin. Curr Opin Cell Biol. 1995;7:32-38.
42. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RGW, Michel T. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem. 1996; 271:6518-6522.
43. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T. Endothelial nitric oxide synthase targeting to caveolae: specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem. 1996;271:22810-22814.
44. Anderson RGW. Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci USA. 1993;90:10909-10913.
45. Levin KR, Page E. Quantitative studies on plasmalemmal folds and caveolae of rabbit ventricular myocardial cells. Circ Res. 1980;46: 244-255.
46. Rodeheffer RJ, Gerstenblith G, Becker LC, Fleg JL, Weisfeldt ML, Lakatta EG. Exercise cardiac output is maintained with increasing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. Circulation. 1984;69:203-213.
47. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res. 1994;74:349-353.
48. Smith CJ, Sun D, Hoegler C, Roth BS, Zhang X, Zhao G, Xu XB, Kobari Y, Pritchard K, Sessa WC, Hintze TH. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res. 1996;78:58-64.
49. Grossman W. Diastolic dysfunction in congestive heart failure. N Engl J Med. 1991;325:1557-1564.